首页 > 最新文献

Journal of Current Glaucoma Practice最新文献

英文 中文
Optic Nerve Head Parameters in Saudi Male Young Adults Using Swept-source Optical Coherence Tomography. 沙特年轻男性视神经头参数扫描源光学相干断层扫描。
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5005/jp-journals-10078-1405
Naveen K Challa

Purpose: To assess the optic nerve head (ONH) parameters in normal male Saudi eyes using swept-source optical coherence tomography (SS-OCT).

Materials and methods: The study included 86 healthy men with a mean age of 23.6 ± 4.82 years. The metrics collected using SS-OCT from each individual was disk area (DA), rim area (RA), cup volume (CV), linear cup-disk ratio (LCDR), vertical cup-disk ratio (VCDR), and total retinal nerve fiber layer (RNFL) thickness, superior RNFL thickness, and inferior RNFL thickness. All the metrics were correlated with the DA. The right eye data were used for the correlation analysis.

Results: The mean DA in OD was 1.78 mm2 (range 1.09-2.70 mm2). The mean RA was 1.28 mm2 (range 0.72-2.47 mm2). The DA showed a significant positive correlation (p < 0.05) with RA, cup area (CA), CV, VCDR, LCDR, and total RNFL thickness.

Conclusion: For the first time, using sweeping source OCT (DRI OCT Triton, Topcon Corporation), a normative database of ONH parameters was made accessible to the Saudi male population. While assessing the optic disk for progressive optic neuropathies like glaucoma, disk size should be taken into consideration since the optic DA affects ONH topography, especially in Saudi eyes.

How to cite this article: Challa NK. Optic Nerve Head Parameters in Saudi Male Young Adults Using Swept-source Optical Coherence Tomography. J Curr Glaucoma Pract 2023;17(2):58-62.

目的:使用扫描源光学相干断层扫描(SS-OCT)评估沙特正常男性眼睛的视神经头(ONH)参数。材料和方法:该研究包括86名平均年龄23.6±4.82岁的健康男性。使用SS-OCT从每个个体收集的指标是椎间盘面积(DA)、边缘面积(RA)、杯体积(CV)、线性杯盘比(LCDR)、垂直杯盘比和总视网膜神经纤维层(RNFL)厚度、上RNFL厚度和下RNFL厚度。所有指标均与DA相关。右眼数据用于相关性分析。结果:OD的平均DA为1.78mm2(范围1.09-2.70mm2)。平均RA为1.28 mm2(范围0.72-2.47 mm2)。DA与RA、杯面积(CA)、CV、VCDR、LCDR和总RNFL厚度呈显著正相关(p<0.05)。结论:使用扫描源OCT(DRI OCT Triton,Topcon Corporation),首次为沙特男性人群提供了ONH参数的标准数据库。在评估进行性视神经病变(如青光眼)的视盘时,应考虑视盘大小,因为视DA会影响ONH地形图,尤其是沙特眼。如何引用这篇文章:Challa NK。沙特年轻男性视神经头参数扫描源光学相干断层扫描。青光眼临床杂志2023;17(2):58-62。
{"title":"Optic Nerve Head Parameters in Saudi Male Young Adults Using Swept-source Optical Coherence Tomography.","authors":"Naveen K Challa","doi":"10.5005/jp-journals-10078-1405","DOIUrl":"10.5005/jp-journals-10078-1405","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the optic nerve head (ONH) parameters in normal male Saudi eyes using swept-source optical coherence tomography (SS-OCT).</p><p><strong>Materials and methods: </strong>The study included 86 healthy men with a mean age of 23.6 ± 4.82 years. The metrics collected using SS-OCT from each individual was disk area (DA), rim area (RA), cup volume (CV), linear cup-disk ratio (LCDR), vertical cup-disk ratio (VCDR), and total retinal nerve fiber layer (RNFL) thickness, superior RNFL thickness, and inferior RNFL thickness. All the metrics were correlated with the DA. The right eye data were used for the correlation analysis.</p><p><strong>Results: </strong>The mean DA in OD was 1.78 mm<sup>2</sup> (range 1.09-2.70 mm<sup>2</sup>). The mean RA was 1.28 mm<sup>2</sup> (range 0.72-2.47 mm<sup>2</sup>). The DA showed a significant positive correlation (<i>p</i> < 0.05) with RA, cup area (CA), CV, VCDR, LCDR, and total RNFL thickness.</p><p><strong>Conclusion: </strong>For the first time, using sweeping source OCT (DRI OCT Triton, Topcon Corporation), a normative database of ONH parameters was made accessible to the Saudi male population. While assessing the optic disk for progressive optic neuropathies like glaucoma, disk size should be taken into consideration since the optic DA affects ONH topography, especially in Saudi eyes.</p><p><strong>How to cite this article: </strong>Challa NK. Optic Nerve Head Parameters in Saudi Male Young Adults Using Swept-source Optical Coherence Tomography. J Curr Glaucoma Pract 2023;17(2):58-62.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 2","pages":"58-62"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/e3/jocgp-17-58.PMC10357028.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10223141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese. 原发性闭角型青光眼患者视野进展的前节段生物力学:马来人和中国人的比较。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1391
F P Neoh, Azhany Y, Azrin Ah Siti, A T Liza-Sharmini

Objective: To compare anterior segment biometry parameters in progress and non-progress primary angle closure glaucoma (PACG) among Malay and Chinese patients.

Materials and methods: A cross-sectional study was conducted between November 2015 and December 2016 involving 75 patients with PACG (43 Malays and 32 Chinese) who were recruited from a single glaucoma center in Malaysia. Ocular examination included anterior segment biometry measurements on the selected eye. Axial length (AL) and anterior chamber depth (ACD) measurement was done using a noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). Anterior chamber angle (ACA) was measured by Anterior Segment-OCT (Spectralis Heidelberg, Germany). Humphrey visual field (HVF) 24-2 analysis of the same eye was conducted and compared with the HVF when diagnosis was made. Progression of PACG patients was assessed according to the Hodapp, Parrish and Anderson's (HPA) classification, they were then divided into progress and non-progress groups. Comparison of anterior segment biometry parameters between Malay and Chinese PACG patients with and without progression was analyzed using independent T test. Multivariate ANOVA analysis was used to compare the anterior segment parameters between progress and non-progress PACG patients, with adjustment for age, gender, lens status, family history and presence of diabetes mellitus.

Results: Chinese PACG patients have significant shorter AL (22.18 mm ± 0.76) and narrower ACA (11.96° ± 6.00) compared to Malay PACG patients. Among the progress group, Chinese PACG patients have significant shorter AL, shallower ACD and narrower ACA compared to Malays. However, after controlling for confounding factors, there was significant difference in ACA between Malay and Chinese PACG. There was also no significant difference of ocular biometry measurement between Chinese and Malay patients in progress and non-progress group.

Conclusion: There was racial influence in ocular biometry measurement in PACG patients. Chinese have significant narrower ACA compared to Malays. Serial AS-OCT monitoring is important in management of PACG.

How to cite this article: Neoh FP, Azhany Y, Siti-Azrin AH, et al. Anterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese. J Curr Glaucoma Pract 2023;17(1):3-8.

目的:比较马来人和中国人进行性和非进行性原发性闭角型青光眼(PACG)患者的眼前节生物测量参数。材料和方法:2015年11月至2016年12月进行了一项横断面研究,涉及75名PACG患者(43名马来人和32名中国人),他们来自马来西亚的一个青光眼中心。眼部检查包括对所选眼睛的前段生物测量。轴向长度(AL)和前房深度(ACD)测量使用非接触部分相干干涉仪(IOL Master,Carl Zeiss,Germany)进行。前房角(ACA)通过前段OCT(Spectralis Heidelberg,德国)测量。对同一只眼睛进行Humphrey视野(HVF)24-2分析,并与诊断时的HVF进行比较。根据Hodapp、Parrish和Anderson(HPA)分类评估PACG患者的进展情况,然后将他们分为进展组和非进展组。使用独立T检验分析了马来和中国PACG患者有无进展的前段生物测量参数的比较。多变量方差分析用于比较进展期和非进展期PACG患者的眼前节参数,并对年龄、性别、晶状体状态、家族史和糖尿病的存在进行了调整。结果:与马来族PACG患者相比,中国PACG患者的AL显著缩短(22.18mm±0.76),ACA显著缩小(11.96°±6.00)。在进展组中,与马来人相比,中国PACG患者的AL明显较短,ACD较浅,ACA较窄。然而,在控制混杂因素后,马来语和汉语PACG之间的ACA存在显著差异。进展组和非进展组的中国和马来患者的眼部生物测量也没有显著差异。结论:PACG患者的眼部生物测量存在种族差异。与马来人相比,华人的ACA明显缩小。AS-OCT系列监测在PACG的管理中很重要。如何引用本文:Neoh FP,Azhany Y,Siti Azrin AH等。视野进展的原发性闭角型青光眼患者的前段生物力学:马来人和中国人的比较。青光眼临床杂志2023;17(1):3-8。
{"title":"Anterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese.","authors":"F P Neoh,&nbsp;Azhany Y,&nbsp;Azrin Ah Siti,&nbsp;A T Liza-Sharmini","doi":"10.5005/jp-journals-10078-1391","DOIUrl":"10.5005/jp-journals-10078-1391","url":null,"abstract":"<p><strong>Objective: </strong>To compare anterior segment biometry parameters in progress and non-progress primary angle closure glaucoma (PACG) among Malay and Chinese patients.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted between November 2015 and December 2016 involving 75 patients with PACG (43 Malays and 32 Chinese) who were recruited from a single glaucoma center in Malaysia. Ocular examination included anterior segment biometry measurements on the selected eye. Axial length (AL) and anterior chamber depth (ACD) measurement was done using a noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). Anterior chamber angle (ACA) was measured by Anterior Segment-OCT (Spectralis Heidelberg, Germany). Humphrey visual field (HVF) 24-2 analysis of the same eye was conducted and compared with the HVF when diagnosis was made. Progression of PACG patients was assessed according to the Hodapp, Parrish and Anderson's (HPA) classification, they were then divided into progress and non-progress groups. Comparison of anterior segment biometry parameters between Malay and Chinese PACG patients with and without progression was analyzed using independent T test. Multivariate ANOVA analysis was used to compare the anterior segment parameters between progress and non-progress PACG patients, with adjustment for age, gender, lens status, family history and presence of diabetes mellitus.</p><p><strong>Results: </strong>Chinese PACG patients have significant shorter AL (22.18 mm ± 0.76) and narrower ACA (11.96° ± 6.00) compared to Malay PACG patients. Among the progress group, Chinese PACG patients have significant shorter AL, shallower ACD and narrower ACA compared to Malays. However, after controlling for confounding factors, there was significant difference in ACA between Malay and Chinese PACG. There was also no significant difference of ocular biometry measurement between Chinese and Malay patients in progress and non-progress group.</p><p><strong>Conclusion: </strong>There was racial influence in ocular biometry measurement in PACG patients. Chinese have significant narrower ACA compared to Malays. Serial AS-OCT monitoring is important in management of PACG.</p><p><strong>How to cite this article: </strong>Neoh FP, Azhany Y, Siti-Azrin AH, <i>et al.</i> Anterior Segment Biometry in Primary Angle Closure Glaucoma Patients with Visual Field Progression: Comparison between Malays and Chinese. J Curr Glaucoma Pract 2023;17(1):3-8.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"3-8"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/95/jocgp-17-3.PMC10203328.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Transscleral Cyclophotocoagulation: New Perspectives for Uncontrolled Glaucoma Management. 经巩膜环形光凝术:非控制性青光眼治疗的新视角。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1398
Fabio N Kanadani, Lilian de F Campos, Syril Dorairaj, Tiago S Prata

How to cite this article: Kanadani FN, F Campos LD, Dorairaj S, et al. Transscleral Cyclophotocoagulation: New Perspectives for Uncontrolled Glaucoma Management. J Curr Glaucoma Pract 2023;17(1):1-2.

如何引用这篇文章:Kanadani FN,F Campos LD,Dorairaj S,et al.经巩膜睫状体光凝术:非控制性青光眼治疗的新视角。青光眼临床杂志2023;17(1):1-2。
{"title":"Transscleral Cyclophotocoagulation: New Perspectives for Uncontrolled Glaucoma Management.","authors":"Fabio N Kanadani,&nbsp;Lilian de F Campos,&nbsp;Syril Dorairaj,&nbsp;Tiago S Prata","doi":"10.5005/jp-journals-10078-1398","DOIUrl":"10.5005/jp-journals-10078-1398","url":null,"abstract":"<p><p><b>How to cite this article:</b> Kanadani FN, F Campos LD, Dorairaj S, <i>et al.</i> Transscleral Cyclophotocoagulation: New Perspectives for Uncontrolled Glaucoma Management. J Curr Glaucoma Pract 2023;17(1):1-2.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/99/80/jocgp-17-1.PMC10203331.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9518289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late-onset Relapse of Aqueous Misdirection after Pars Plana Vitrectomy: Case Report and Literature Review. 玻璃体平板切除术后迟发性复发性水性错位:病例报告和文献复习。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1397
Ioannis Halkiadakis, Vasillios Tzimis, Ioannis Markopoulos, Stylianos A Kandarakis, Vasilliki Konstadinidou, Michalis Tzakos

Aim: We report on an 88-year-old female patient who presented with a relapse in aqueous misdirection 15 years after being treated with pars plana vitrectomy (PPV) with hyaloidotomy-zonulectomy-iridotomy (HZI) for the same cause.

Case description: A 73-year-old pseudophakic woman with a history of pseudoexfoliation underwent a trabeculectomy in the left eye in our institution because of uncontrolled intraocular pressure. Days after trabeculectomy, the patient developed aqueous misdirection and was treated with PPV combined with HZI. In the following years, the patient had regular follow-up appointments in our instruction, and she had normal intraocular pressures in the left eye without any treatment. A total of 15 years after the vitrectomy, the patient developed gradual swallowing in the anterior chamber and increased intraocular pressure. Neodymium (Nd): yttrium aluminum garnet (YAG) laser hyaloidotomy through the iridectomy opening was performed, the anterior chamber was immediately deepened, and the intraocular pressure was reduced to normal limits. The anterior chamber remained deep, and the intraocular pressure remained normal through the 36 months of follow-up.

Conclusion: Relapse of aqueous misdirection may occur many years after vitrectomy, even when HZI is performed. An Nd: YAG- laser hyaloidotomy should be attempted before a second HZI is considered.

Clinical relevance: A close and long-lasting follow-up of patients with aqueous misdirection is warranted, especially if the patients are treated not with complete PPV but by a limited disruption of the anterior hyaloid face along with HIZ.

How to cite this article: Halkiadakis I, Tzimis V, Markopoulos I, et al. Late-onset Relapse of Aqueous Misdirection after Pars Plana Vitrectomy: Case Report and Literature Review. J Curr Glaucoma Pract 2023;17(1):49-51.

目的:我们报告一名88岁的女性患者,该患者在接受平坦部玻璃体切除术(PPV)和玻璃体切除带切除术-虹膜切开术(HZI)治疗15年后,再次出现水性误导。病例描述:一名73岁的有假脱落病史的人工晶状体妇女因眼压失控,在我们机构接受了左眼小梁切除术。小梁切除术后几天,患者出现水性误导,接受PPV联合HZI治疗。在接下来的几年里,患者在我们的指导下定期随访,她在没有任何治疗的情况下左眼眼压正常。玻璃体切除术后15年,患者出现前房逐渐吞咽,眼压升高。通过虹膜切除术开口进行钕(Nd):钇铝石榴石(YAG)激光玻璃体切除术,前房立即加深,眼压降至正常范围。在36个月的随访中,前房仍然很深,眼压保持正常。在考虑第二次HZI之前,应尝试Nd:YAG激光玻璃体切除术。临床相关性:对水性误导患者进行密切而持久的随访是有必要的,尤其是如果患者不是用完全的PPV治疗,而是用有限的前玻璃体面破坏和HIZ治疗。如何引用这篇文章:Halkiadakis I,Tzimis V,Markopoulos I等人。玻璃体平板切除术后迟发性复发性水性错位:病例报告和文献复习。青光眼临床杂志2023;17(1):49-51。
{"title":"Late-onset Relapse of Aqueous Misdirection after Pars Plana Vitrectomy: Case Report and Literature Review.","authors":"Ioannis Halkiadakis,&nbsp;Vasillios Tzimis,&nbsp;Ioannis Markopoulos,&nbsp;Stylianos A Kandarakis,&nbsp;Vasilliki Konstadinidou,&nbsp;Michalis Tzakos","doi":"10.5005/jp-journals-10078-1397","DOIUrl":"10.5005/jp-journals-10078-1397","url":null,"abstract":"<p><strong>Aim: </strong>We report on an 88-year-old female patient who presented with a relapse in aqueous misdirection 15 years after being treated with pars plana vitrectomy (PPV) with hyaloidotomy-zonulectomy-iridotomy (HZI) for the same cause.</p><p><strong>Case description: </strong>A 73-year-old pseudophakic woman with a history of pseudoexfoliation underwent a trabeculectomy in the left eye in our institution because of uncontrolled intraocular pressure. Days after trabeculectomy, the patient developed aqueous misdirection and was treated with PPV combined with HZI. In the following years, the patient had regular follow-up appointments in our instruction, and she had normal intraocular pressures in the left eye without any treatment. A total of 15 years after the vitrectomy, the patient developed gradual swallowing in the anterior chamber and increased intraocular pressure. Neodymium (Nd): yttrium aluminum garnet (YAG) laser hyaloidotomy through the iridectomy opening was performed, the anterior chamber was immediately deepened, and the intraocular pressure was reduced to normal limits. The anterior chamber remained deep, and the intraocular pressure remained normal through the 36 months of follow-up.</p><p><strong>Conclusion: </strong>Relapse of aqueous misdirection may occur many years after vitrectomy, even when HZI is performed. An Nd: YAG- laser hyaloidotomy should be attempted before a second HZI is considered.</p><p><strong>Clinical relevance: </strong>A close and long-lasting follow-up of patients with aqueous misdirection is warranted, especially if the patients are treated not with complete PPV but by a limited disruption of the anterior hyaloid face along with HIZ.</p><p><strong>How to cite this article: </strong>Halkiadakis I, Tzimis V, Markopoulos I, <i>et al.</i> Late-onset Relapse of Aqueous Misdirection after Pars Plana Vitrectomy: Case Report and Literature Review. J Curr Glaucoma Pract 2023;17(1):49-51.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"49-51"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/8c/jocgp-17-49.PMC10203336.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced Visibility of the Retinal Nerve Fiber Layer Defects by the Underlying Diffuse Choroidal Angioma in Sturge Weber Syndrome with Glaucoma. Sturge-Weber综合征合并青光眼的弥漫性脉络膜血管瘤增强视网膜神经纤维层缺陷的可见性。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1385
Ahmed M Abdelrahman

Aim: To describe a unique finding in a patient with Sturge-Weber syndrome (SWS) accompanied by glaucoma.

Background: Cases with SWS may have an associated choroidal angioma and glaucoma. The localized retinal nerve fiber layer (RNFL) defects induced by the associated glaucoma are better detected against the red background of the associated choroidal angioma.

Case description: A 15-year-old boy was presented with left-side SWS. The case was subjected to full clinical examination, intraocular pressure (IOP) measurements, color fundus photography, ultrasonography, visual field assessment, and optical coherence tomography (OCT) of the peripapillary RNFL and ganglion cell layer (GCC) analysis. The main clinical finding was the enhanced detection of defects of the RNFL against the red color of associated choroidal angioma in this glaucomatous eye.

Conclusion: There is enhanced clinical visibility of RNFL defects in presence of associated diffuse choroidal angioma in Sturge-Weber glaucoma.

Clinical significance: Easier clinical detection of RNFL defects in SWS glaucoma associated with diffuse choroidal angioma.

How to cite this article: Abdelrahman AM. Enhanced Visibility of the Retinal Nerve Fiber Layer Defects by the underlying Diffuse Choroidal Angioma in Sturge Weber Syndrome with Glaucoma. J Curr Glaucoma Pract 2023;17(1):52-54.

目的:描述一例伴有青光眼的斯特-韦伯综合征(SWS)患者的独特发现。背景:SWS患者可能伴有脉络膜血管瘤和青光眼。相关青光眼引起的局部视网膜神经纤维层(RNFL)缺陷在相关脉络膜血管瘤的红色背景下可以更好地检测到。病例描述:一名15岁男孩出现左侧SWS。对该病例进行了全面的临床检查、眼压(IOP)测量、眼底彩色摄影、超声检查、视野评估以及乳头周围RNFL的光学相干断层扫描(OCT)和神经节细胞层(GCC)分析。主要的临床发现是在这只青光眼眼睛中,RNFL的缺陷对相关脉络膜血管瘤的红色的检测增强。结论:在伴有弥漫性脉络膜血管瘤的Sturge-Weber型青光眼中,RNFL缺陷的临床可见度提高。临床意义:在伴有弥漫性脉络膜血管瘤的SWS型青光眼中更容易检测RNFL缺陷。如何引用这篇文章:Abdelrahman AM。Sturge-Weber综合征合并青光眼的弥漫性脉络膜血管瘤增强视网膜神经纤维层缺陷的可见性。青光眼临床杂志2023;17(1):52-54。
{"title":"Enhanced Visibility of the Retinal Nerve Fiber Layer Defects by the Underlying Diffuse Choroidal Angioma in Sturge Weber Syndrome with Glaucoma.","authors":"Ahmed M Abdelrahman","doi":"10.5005/jp-journals-10078-1385","DOIUrl":"10.5005/jp-journals-10078-1385","url":null,"abstract":"<p><strong>Aim: </strong>To describe a unique finding in a patient with Sturge-Weber syndrome (SWS) accompanied by glaucoma.</p><p><strong>Background: </strong>Cases with SWS may have an associated choroidal angioma and glaucoma. The localized retinal nerve fiber layer (RNFL) defects induced by the associated glaucoma are better detected against the red background of the associated choroidal angioma.</p><p><strong>Case description: </strong>A 15-year-old boy was presented with left-side SWS. The case was subjected to full clinical examination, intraocular pressure (IOP) measurements, color fundus photography, ultrasonography, visual field assessment, and optical coherence tomography (OCT) of the peripapillary RNFL and ganglion cell layer (GCC) analysis. The main clinical finding was the enhanced detection of defects of the RNFL against the red color of associated choroidal angioma in this glaucomatous eye.</p><p><strong>Conclusion: </strong>There is enhanced clinical visibility of RNFL defects in presence of associated diffuse choroidal angioma in Sturge-Weber glaucoma.</p><p><strong>Clinical significance: </strong>Easier clinical detection of RNFL defects in SWS glaucoma associated with diffuse choroidal angioma.</p><p><strong>How to cite this article: </strong>Abdelrahman AM. Enhanced Visibility of the Retinal Nerve Fiber Layer Defects by the underlying Diffuse Choroidal Angioma in Sturge Weber Syndrome with Glaucoma. J Curr Glaucoma Pract 2023;17(1):52-54.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"52-54"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/e7/jocgp-17-52.PMC10203333.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Comparison of Age-related Change in Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses between Glaucoma Suspects and Healthy Individuals. 青光眼患者和健康人视网膜神经纤维层和神经节细胞复合体厚度的年龄相关性变化的比较。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1392
Goktug Firatli, Alperen Elibol, Ekin Altinbas, Cemre Ayhan, Ali Riza Cenk Celebi

Aim: The purpose of this study is to investigate the difference of change in the retinal nerve fiber layer (RNFL) and the ganglion cell complex (GCC) thickness according to age in glaucoma suspect individuals and healthy subjects.

Materials and methods: Thicknesses of RNFL and GCC were measured with spectral domain optical coherence tomography (SD-OCT) in glaucoma-suspected individuals and healthy subjects. The differences in age, overall mean, four quadrants, and 12 clock-hour sectors of RNFL and overall mean, superior half, and inferior half GCC thicknesses between glaucoma suspects and healthy participants were analyzed and compared using linear regression analyses.

Results: There were 201 glaucoma-suspect individuals and 121 healthy subjects with a mean age of 38.89 and 40.26 years, respectively (p = 0.27). The mean overall RNFL thickness was found to be 97.76 and 97.43 µm in healthy individuals and glaucoma suspects (p = 0.72). The mean overall GCC thickness was found to be 111.30 and 104.67 µm in healthy individuals and glaucoma suspects, respectively (p < 0.001). There was a 0.11 µm decrease per year found in overall GCC thickness in glaucoma suspects and 0.23 µm decreases per year in overall GCC thickness in healthy individuals (p < 0.001). There was a 0.02 µm decrease per year found in overall RNFL thickness in glaucoma suspects and a 0.29 µm decrease per year in overall RNFL thickness in healthy individuals (p < 0.001). However, these per-year decreases in GCC thickness glaucoma suspects and healthy individuals were not found to be statistically significant (p = 0.21); on the other hand, this difference for RNFL thickness was significant (p < 0.001).

Conclusion: It was found that the thicknesses of RNFL and GCC were different between glaucoma suspects and healthy individuals. However, age-related decay in the RNFL and GCC thicknesses was not uniform in healthy individuals and glaucoma suspects.

Clinical significance: It was found that the RNFL thickness and GCC thickness were lower in glaucoma suspects than in healthy controls eyes. However, an age-related decrease of RNFL and GCC thicknesses were found to be less in glaucoma suspects compared with healthy controls.

How to cite this article: Firatli G, Elibol A, Altinbas E, et al. The Comparison of Age-related Change in Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses between Glaucoma Suspects and Healthy Individuals. J Curr Glaucoma Pract 2023;17(1):22-29.

目的:研究青光眼可疑个体和健康受试者视网膜神经纤维层(RNFL)和神经节细胞复合体(GCC)厚度随年龄变化的差异。材料和方法:用光谱域光学相干断层扫描(SD-OCT)测量疑似青光眼患者和健康受试者的RNFL和GCC厚度。使用线性回归分析分析和比较青光眼嫌疑人和健康参与者在年龄、RNFL的总体平均值、四个象限和12个时钟小时扇区以及GCC的总体平均、上半部和下半部厚度方面的差异。结果:201名青光眼可疑个体和121名健康受试者,平均年龄分别为38.89岁和40.26岁(p=0.27)。健康个体和青光眼可疑个体的平均总RNFL厚度分别为97.76和97.43µm(p=0.72)。健康个人和青光眼可疑者的平均总GCC厚度分别为111.30和104.67µm,青光眼患者的GCC总厚度每年下降0.11µm,健康人的GCC总厚每年下降0.23µm(p<0.001)。青光眼患者的RNFL总厚度每年减少0.02µm,而健康人的RNFL厚度每年减少0.29µm(p<0.001)。然而,GCC厚度青光眼嫌疑人和健康个体每年的下降没有统计学意义(p=0.21);另一方面,这种RNFL厚度的差异是显著的(p<0.001)。结论:青光眼患者和健康人的RNFL和GCC厚度不同。然而,在健康个体和青光眼患者中,RNFL和GCC厚度的年龄相关性衰减并不均匀。临床意义:发现可疑青光眼患者的RNFL厚度和GCC厚度低于健康对照眼。然而,与健康对照组相比,疑似青光眼患者的RNFL和GCC厚度与年龄相关的减少较少。如何引用这篇文章:Firatli G,Elibol A,Altinbas E等。青光眼疑似患者和健康人视网膜神经纤维层和神经节细胞复合体厚度的年龄相关变化的比较。青光眼临床杂志2023;17(1):22-29。
{"title":"The Comparison of Age-related Change in Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses between Glaucoma Suspects and Healthy Individuals.","authors":"Goktug Firatli,&nbsp;Alperen Elibol,&nbsp;Ekin Altinbas,&nbsp;Cemre Ayhan,&nbsp;Ali Riza Cenk Celebi","doi":"10.5005/jp-journals-10078-1392","DOIUrl":"10.5005/jp-journals-10078-1392","url":null,"abstract":"<p><strong>Aim: </strong>The purpose of this study is to investigate the difference of change in the retinal nerve fiber layer (RNFL) and the ganglion cell complex (GCC) thickness according to age in glaucoma suspect individuals and healthy subjects.</p><p><strong>Materials and methods: </strong>Thicknesses of RNFL and GCC were measured with spectral domain optical coherence tomography (SD-OCT) in glaucoma-suspected individuals and healthy subjects. The differences in age, overall mean, four quadrants, and 12 clock-hour sectors of RNFL and overall mean, superior half, and inferior half GCC thicknesses between glaucoma suspects and healthy participants were analyzed and compared using linear regression analyses.</p><p><strong>Results: </strong>There were 201 glaucoma-suspect individuals and 121 healthy subjects with a mean age of 38.89 and 40.26 years, respectively (<i>p</i> = 0.27). The mean overall RNFL thickness was found to be 97.76 and 97.43 µm in healthy individuals and glaucoma suspects (<i>p</i> = 0.72). The mean overall GCC thickness was found to be 111.30 and 104.67 µm in healthy individuals and glaucoma suspects, respectively (<i>p</i> < 0.001). There was a 0.11 µm decrease per year found in overall GCC thickness in glaucoma suspects and 0.23 µm decreases per year in overall GCC thickness in healthy individuals (<i>p</i> < 0.001). There was a 0.02 µm decrease per year found in overall RNFL thickness in glaucoma suspects and a 0.29 µm decrease per year in overall RNFL thickness in healthy individuals (<i>p</i> < 0.001). However, these per-year decreases in GCC thickness glaucoma suspects and healthy individuals were not found to be statistically significant (<i>p</i> = 0.21); on the other hand, this difference for RNFL thickness was significant (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>It was found that the thicknesses of RNFL and GCC were different between glaucoma suspects and healthy individuals. However, age-related decay in the RNFL and GCC thicknesses was not uniform in healthy individuals and glaucoma suspects.</p><p><strong>Clinical significance: </strong>It was found that the RNFL thickness and GCC thickness were lower in glaucoma suspects than in healthy controls eyes. However, an age-related decrease of RNFL and GCC thicknesses were found to be less in glaucoma suspects compared with healthy controls.</p><p><strong>How to cite this article: </strong>Firatli G, Elibol A, Altinbas E, <i>et al.</i> The Comparison of Age-related Change in Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses between Glaucoma Suspects and Healthy Individuals. J Curr Glaucoma Pract 2023;17(1):22-29.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"22-29"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c2/57/jocgp-17-22.PMC10203334.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes. 微脉冲经巩膜睫状体光凝术的临床疗效:葡萄牙眼2年经验。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1395
Rita C Basto, Júlio Almeida, Joana N Roque, Susana P Henriques, Ana S Gonçalves, Fernando T Vaz, Helena Carvalho, Isabel Prieto

Aim: This study evaluates the safety and efficacy of micropulse transscleral cyclophotocoagulation (MPTSCPC) in glaucoma patients, with standard parameters, over a 24-month period.

Methods: Retrospective analysis of 61 eyes undergoing MPTSCPC from January 2018 to December 2020 was carried out. Patients received 160 seconds of laser, with settings of 2000 mW/cm2 and a duty cycle of 31.3%.

Results: A total of 61 eyes were included, arranged in an age distribution of 73.9 ± 10.8 years. The most frequent diagnosis was primary open-angle glaucoma (POAG), with a mean best-corrected visual acuity (BCVA) of 5/10 in the Snellen Visual chart. Around 37.7% of the eyes had undergone at least one glaucoma filtration surgery prior to MPTSCPC. The mean pretreatment intraocular pressure (IOP) was 24.9 ± 8.6 mm Hg. Except for the contrast at 24 months, at every other follow-up visit, there was a significant reduction (p ≤ 0.001) in IOP and in the number of topical drugs required to control IOP, from four (baseline) to three, with oral acetazolamide suspension in most cases. The total success rate (absolute and clinical successes combined) was 81.9% after 1 year of the treatment. There was no drop in visual acuity or cases of serious complications. There is a positive and significant correlation between prior glaucoma surgery and the need for reinterventions (p = 0.028).

Conclusions: Micropulse transscleral cyclophotocoagulation (MPTSCPC) is an effective and safe procedure for reducing IOP within a broad spectrum of glaucoma patients. Additional studies are needed to confirm the current indications, widen their scope, and determine the optimal treatment settings on an individual basis.

How to cite this article: Basto RC, Almeida J, Roque JN, et al. Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes. J Curr Glaucoma Pract 2023;17(1):30-36.

目的:本研究采用标准参数,在24个月内评估微脉冲经巩膜睫状体光凝术(MPTSSPC)治疗青光眼患者的安全性和有效性。方法:对2018年1月至2020年12月接受MPTSSPC治疗的61眼患者进行回顾性分析。患者接受了160秒的激光,激光设置为2000mW/cm2,占空比为31.3%。结果:共有61只眼睛,年龄分布为73.9±10.8岁。最常见的诊断是原发性开角型青光眼(POAG),Snellen视力表中的平均最佳矫正视力(BCVA)为5/10。大约37.7%的眼睛在MPTSSPC之前至少接受过一次青光眼滤过手术。术前平均眼压为24.9±8.6mmHg。除了24个月时的对比外,在其他每一次随访中,大多数情况下,口服乙酰唑胺混悬液可使眼压和控制眼压所需的局部药物数量从4种(基线)显著减少(p≤0.001)。治疗1年后,总成功率(绝对成功率和临床成功率的总和)为81.9%。视力没有下降,也没有出现严重并发症。既往青光眼手术与再次干预的必要性之间存在正相关(p=0.028)。结论:微脉冲经巩膜睫状体光凝术(MPTSSPC)是一种有效且安全的方法,可在广泛的青光眼患者中降低眼压。需要进行更多的研究来确认当前的适应症,扩大其范围,并在个体基础上确定最佳治疗设置。如何引用这篇文章:Basto RC,Almeida J,Roque JN,et al.微脉冲经巩膜睫状体光凝术的临床结果:在葡萄牙人眼中的2年经验。青光眼临床杂志2023;17(1):30-36。
{"title":"Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes.","authors":"Rita C Basto,&nbsp;Júlio Almeida,&nbsp;Joana N Roque,&nbsp;Susana P Henriques,&nbsp;Ana S Gonçalves,&nbsp;Fernando T Vaz,&nbsp;Helena Carvalho,&nbsp;Isabel Prieto","doi":"10.5005/jp-journals-10078-1395","DOIUrl":"10.5005/jp-journals-10078-1395","url":null,"abstract":"<p><strong>Aim: </strong>This study evaluates the safety and efficacy of micropulse transscleral cyclophotocoagulation (MPTSCPC) in glaucoma patients, with standard parameters, over a 24-month period.</p><p><strong>Methods: </strong>Retrospective analysis of 61 eyes undergoing MPTSCPC from January 2018 to December 2020 was carried out. Patients received 160 seconds of laser, with settings of 2000 mW/cm<sup>2</sup> and a duty cycle of 31.3%.</p><p><strong>Results: </strong>A total of 61 eyes were included, arranged in an age distribution of 73.9 ± 10.8 years. The most frequent diagnosis was primary open-angle glaucoma (POAG), with a mean best-corrected visual acuity (BCVA) of 5/10 in the Snellen Visual chart. Around 37.7% of the eyes had undergone at least one glaucoma filtration surgery prior to MPTSCPC. The mean pretreatment intraocular pressure (IOP) was 24.9 ± 8.6 mm Hg. Except for the contrast at 24 months, at every other follow-up visit, there was a significant reduction (<i>p</i> ≤ 0.001) in IOP and in the number of topical drugs required to control IOP, from four (baseline) to three, with oral acetazolamide suspension in most cases. The total success rate (absolute and clinical successes combined) was 81.9% after 1 year of the treatment. There was no drop in visual acuity or cases of serious complications. There is a positive and significant correlation between prior glaucoma surgery and the need for reinterventions (<i>p</i> = 0.028).</p><p><strong>Conclusions: </strong>Micropulse transscleral cyclophotocoagulation (MPTSCPC) is an effective and safe procedure for reducing IOP within a broad spectrum of glaucoma patients. Additional studies are needed to confirm the current indications, widen their scope, and determine the optimal treatment settings on an individual basis.</p><p><strong>How to cite this article: </strong>Basto RC, Almeida J, Roque JN, <i>et al.</i> Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation: 2 Years of Experience in Portuguese Eyes. J Curr Glaucoma Pract 2023;17(1):30-36.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"30-36"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/50/jocgp-17-30.PMC10203329.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey. Rho激酶抑制剂在眼科疾病中的应用:转化研究之旅。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1396
Kirti Singh, Arshi Singh

Aim: This review summarizes current data on Rho-kinase (ROCK) inhibitors use in ocular diseases, primarily glaucoma.

Background: Translational research over the last decade culminating in the development of ROCK inhibitors has provided a much-needed shot in the arm to glaucoma pharmacopeia. ROCK pathway is intricately involved in cytoskeletal modulation with action on cell morphology, cell motility, cell adhesion, cell apoptosis, and smooth muscle contraction. This cytoskeletal modulation property has been utilized to modify trabecular meshwork (TM) resistance, resulting in the discovery of ROCK inhibitors to increase trabecular outflow.

Review results: Multicentric trials on ROCK inhibitors for antiglaucoma medications are summarized. The focus is on linking pharmacological action to the clinical utility of these drugs. While the Rho Kinase Elevated intraocular Pressure (IOP) Treatment (ROCKET) trials compared monotherapy with ROCK inhibitor netarsudil vs timolol, MERCURY trials compared a fixed dose combination of latanoprost and ROCK inhibitor netarsudil [fixed combination netarsudil-latanoprost (FCNL)] vs monotherapy with either and bimatoprost-timolol combination. While ROCKET trials showed ROCK inhibitors to be non-inferior to timolol, MERCURY trials showed FCNL achieving a much greater IOP reduction than monotherapy with either. Conjunctival hyperemia was the most common side effect reported with ROCK inhibitor use.

Conclusion: Moderate efficacy of ROCK inhibitors with a common side effect of conjunctival hyperemia, makes it an adjunctive antiglaucoma drug of choice and not a first-line therapy.

Clinical significance: ROCK inhibitors' action on diseased TM is more physiological compared to available antiglaucoma medications that either reduce aqueous secretion or enhance uveoscleral outflow. The property of ROCK inhibition to stabilize the endothelium of both retinal vasculature and cornea has opened a new chapter in the treatment of diabetic retinopathy and corneal decompensation.

How to cite this article: Singh K, Singh A. Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey. J Curr Glaucoma Pract 2023;17(1):44-48.

目的:本文综述了Rho激酶(ROCK)抑制剂在眼部疾病(主要是青光眼)中的应用。背景:过去十年的转化研究最终开发出ROCK抑制剂,为青光眼药典提供了急需的强心针。ROCK通路复杂地参与细胞骨架调节,对细胞形态、细胞运动、细胞粘附、细胞凋亡和平滑肌收缩起作用。这种细胞骨架调节特性已被用于改变小梁网(TM)阻力,从而发现了增加小梁流出的ROCK抑制剂。综述结果:综述了ROCK抑制剂抗青光眼药物的多中心试验。重点是将药理作用与这些药物的临床应用联系起来。Rho激酶升高眼压(IOP)治疗(ROCKET)试验比较了ROCK抑制剂耐塔舒地尔和噻吗洛尔的单药治疗,而MERCURY试验比较了拉坦前列素和ROCK抑制剂奈塔舒地尔的固定剂量组合[拉坦前列肽固定组合(FCNL)]与任一种和比马前列素-噻吗洛尔组合的单药疗法。虽然ROCKET试验表明ROCK抑制剂不劣于噻吗洛尔,但MERCURY试验表明,FCNL比单一疗法的IOP降低幅度大得多。结膜充血是ROCK抑制剂使用最常见的副作用。结论:ROCK抑制剂疗效中等,常见副作用为结膜充血,是一种辅助抗青光眼药物,而不是一线治疗。临床意义:与减少水分泌或增强葡萄膜巩膜流出的现有抗青光眼药物相比,ROCK抑制剂对患病TM的作用更具生理意义。ROCK抑制视网膜血管系统和角膜内皮的特性为糖尿病视网膜病变和角膜失代偿的治疗翻开了新的篇章。如何引用这篇文章:Singh K,Singh A.Rho激酶抑制剂在眼科疾病中的应用:转化研究之旅。青光眼临床杂志2023;17(1):44-48。
{"title":"Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey.","authors":"Kirti Singh,&nbsp;Arshi Singh","doi":"10.5005/jp-journals-10078-1396","DOIUrl":"10.5005/jp-journals-10078-1396","url":null,"abstract":"<p><strong>Aim: </strong>This review summarizes current data on Rho-kinase (ROCK) inhibitors use in ocular diseases, primarily glaucoma.</p><p><strong>Background: </strong>Translational research over the last decade culminating in the development of ROCK inhibitors has provided a much-needed shot in the arm to glaucoma pharmacopeia. ROCK pathway is intricately involved in cytoskeletal modulation with action on cell morphology, cell motility, cell adhesion, cell apoptosis, and smooth muscle contraction. This cytoskeletal modulation property has been utilized to modify trabecular meshwork (TM) resistance, resulting in the discovery of ROCK inhibitors to increase trabecular outflow.</p><p><strong>Review results: </strong>Multicentric trials on ROCK inhibitors for antiglaucoma medications are summarized. The focus is on linking pharmacological action to the clinical utility of these drugs. While the Rho Kinase Elevated intraocular Pressure (IOP) Treatment (ROCKET) trials compared monotherapy with ROCK inhibitor netarsudil vs timolol, MERCURY trials compared a fixed dose combination of latanoprost and ROCK inhibitor netarsudil [fixed combination netarsudil-latanoprost (FCNL)] vs monotherapy with either and bimatoprost-timolol combination. While ROCKET trials showed ROCK inhibitors to be non-inferior to timolol, MERCURY trials showed FCNL achieving a much greater IOP reduction than monotherapy with either. Conjunctival hyperemia was the most common side effect reported with ROCK inhibitor use.</p><p><strong>Conclusion: </strong>Moderate efficacy of ROCK inhibitors with a common side effect of conjunctival hyperemia, makes it an adjunctive antiglaucoma drug of choice and not a first-line therapy.</p><p><strong>Clinical significance: </strong>ROCK inhibitors' action on diseased TM is more physiological compared to available antiglaucoma medications that either reduce aqueous secretion or enhance uveoscleral outflow. The property of ROCK inhibition to stabilize the endothelium of both retinal vasculature and cornea has opened a new chapter in the treatment of diabetic retinopathy and corneal decompensation.</p><p><strong>How to cite this article: </strong>Singh K, Singh A. Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey. J Curr Glaucoma Pract 2023;17(1):44-48.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"44-48"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/76/jocgp-17-44.PMC10203326.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
New Gonioscopy Technique for Finding Schwalbe's Line: The Ortiz Maneuver. 寻找Schwalbe线的新Gonioscopy技术:Ortiz机动。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1399
Oscar Albis-Donado, Gabriel E Ortiz-Arismendi, Shibal Bhartiya

A new technique for performing gonioscopy that facilitates finding Schwalbe´s line, and lowers the amount of time and light that enters through the pupil is presented. The technique is an alternative to the classic corneal wedge technique and is feasible in the horizontal quadrants without further adjustments to the slit lamp, in contrast to the tilting usually needed for these quadrants. Clinical photos and online videos are presented.

How to cite this article: Albis-Donado O, Ortiz-Arismendi GE, Bhartiya S. New Gonioscopy Technique for Finding Schwalbe's Line: The Ortiz Maneuver. J Curr Glaucoma Pract 2023;17(1):37-39.

提出了一种进行角镜检查的新技术,该技术有助于找到Schwalbe线,并减少通过瞳孔进入的时间和光线量。该技术是经典角膜楔技术的替代方案,在水平象限中是可行的,无需对裂隙灯进行进一步调整,而这些象限通常需要倾斜。展示了临床照片和在线视频。如何引用这篇文章:Albis Donado O,Ortiz Arismendi GE,Bhartiya S.寻找Schwalbe线的新Gonioscopy技术:Ortiz机动。青光眼临床杂志2023;17(1):37-39。
{"title":"New Gonioscopy Technique for Finding Schwalbe's Line: The Ortiz Maneuver.","authors":"Oscar Albis-Donado,&nbsp;Gabriel E Ortiz-Arismendi,&nbsp;Shibal Bhartiya","doi":"10.5005/jp-journals-10078-1399","DOIUrl":"10.5005/jp-journals-10078-1399","url":null,"abstract":"<p><p>A new technique for performing gonioscopy that facilitates finding Schwalbe´s line, and lowers the amount of time and light that enters through the pupil is presented. The technique is an alternative to the classic corneal wedge technique and is feasible in the horizontal quadrants without further adjustments to the slit lamp, in contrast to the tilting usually needed for these quadrants. Clinical photos and online videos are presented.</p><p><strong>How to cite this article: </strong>Albis-Donado O, Ortiz-Arismendi GE, Bhartiya S. New Gonioscopy Technique for Finding Schwalbe's Line: The Ortiz Maneuver. J Curr Glaucoma Pract 2023;17(1):37-39.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"37-39"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/cf/jocgp-17-37.PMC10203330.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9518284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Micropulse Cyclophotocoagulation vs Selective Laser Trabeculoplasty: Effects on Corneal Endothelial Cells and Intraocular Pressure. 微脉冲周期光凝与选择性激光小梁成形术:对角膜内皮细胞和眼压的影响。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.5005/jp-journals-10078-1393
Aylin Garip Kuebler, Siegfried Priglinger, Lukas Reznicek

Purpose: To evaluate the effects of micropulse transscleral cyclophotocoagulation (mCPC) and selective laser trabeculoplasty (SLT) on endothelial cell density (ECD) and reduction of the intraocular pressure (IOP) in patients with primary-open angle glaucoma (POAG).

Patients and methods: In this observational, retrospective study, 40 eyes with POAG were included. Patients were divided into three groups-group I was treated with SLT (n = 13), group II was treated with mCPC (n = 13), and group III included age-matched patients with medically treated glaucoma (n = 14) (control group). In both treatment groups (SLT and mCPC) preoperative and postoperative findings of best-corrected visual acuity (BCVA), ECD, and IOP were compared to the control group.

Results: The mean time interval before and after the treatment was 215 ± 120 days in group I (SLT) and 273 ± 177 days in group II (mCPC). The follow-up for group III (control group) was 209 ± 103 days. In both treatment groups (SLT and mCPC) there was a statistically significant reduction of the IOP postoperatively (group I: 3.5 ± 3.7 mm Hg (p = 0.005) and group II: 4.3 ± 4.1 mm Hg (p = 0.003)). The mean IOP for group III was 12.9 ± 3.7 mm Hg at visit 1 and did not change significantly (p = 0.353) at visit 2. In all three groups, there was no statistically significant change in ECD at the last visit.

Conclusion: According to our results, both SLT and mCPC seem to be effective in lowering the IOP, without showing any statistically significant effect on ECD in patients with POAG.However, larger and longer-term studies are necessary to understand the effects of the SLT and mCPC procedures on ECD.

How to cite this article: Garip Kuebler A, Priglinger S, Reznicek L. Micropulse Cyclophotocoagulation vs Selective Laser Trabeculoplasty: Effects on Corneal Endothelial Cells and Intraocular Pressure. J Curr Glaucoma Pract 2023;17(1):40-43.

目的:评价微脉冲经巩膜睫状体光凝术(mPCC)和选择性激光小梁成形术(SLT)对原发性开角型青光眼(POAG)患者内皮细胞密度(ECD)和眼压降低(IOP)的影响。患者分为三组,第一组接受SLT治疗(n=13),第二组接受mPCC治疗(n=14),第三组包括年龄匹配的药物治疗青光眼患者(n=14,对照组)。在两个治疗组(SLT和mPCC)中,将最佳矫正视力(BCVA)、ECD和IOP的术前和术后结果与对照组进行比较。结果:治疗前后的平均时间间隔I组(SLT)为215±120天,II组(mPCC)为273±177天。第三组(对照组)随访209±103天。在两个治疗组(SLT和mPCC)中,术后眼压均有统计学意义的降低(I组:3.5±3.7 mm Hg(p=0.005)和II组:4.3±4.1 mm Hg(p=0.003))。第III组的平均眼压在第1次就诊时为12.9±3.7 mm汞柱,在第2次就诊时没有显著变化(p=0.353)。在所有三组中,最后一次就诊时ECD没有统计学上的显著变化。结论:根据我们的研究结果,SLT和mPCC似乎都能有效降低IOP,但对POAG患者的ECD没有任何统计学上的显著影响。然而,有必要进行更大规模和更长期的研究来了解SLT和CPC程序对ECD的影响。如何引用这篇文章:Garip Kuebler A,Priglinger S,Reznicek L。微脉冲周期光凝与选择性激光小梁成形术:对角膜内皮细胞和眼压的影响。青光眼临床杂志2023;17(1):40-43。
{"title":"Micropulse Cyclophotocoagulation vs Selective Laser Trabeculoplasty: Effects on Corneal Endothelial Cells and Intraocular Pressure.","authors":"Aylin Garip Kuebler,&nbsp;Siegfried Priglinger,&nbsp;Lukas Reznicek","doi":"10.5005/jp-journals-10078-1393","DOIUrl":"10.5005/jp-journals-10078-1393","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effects of micropulse transscleral cyclophotocoagulation (mCPC) and selective laser trabeculoplasty (SLT) on endothelial cell density (ECD) and reduction of the intraocular pressure (IOP) in patients with primary-open angle glaucoma (POAG).</p><p><strong>Patients and methods: </strong>In this observational, retrospective study, 40 eyes with POAG were included. Patients were divided into three groups-group I was treated with SLT (<i>n</i> = 13), group II was treated with mCPC (<i>n</i> = 13), and group III included age-matched patients with medically treated glaucoma (<i>n</i> = 14) (control group). In both treatment groups (SLT and mCPC) preoperative and postoperative findings of best-corrected visual acuity (BCVA), ECD, and IOP were compared to the control group.</p><p><strong>Results: </strong>The mean time interval before and after the treatment was 215 ± 120 days in group I (SLT) and 273 ± 177 days in group II (mCPC). The follow-up for group III (control group) was 209 ± 103 days. In both treatment groups (SLT and mCPC) there was a statistically significant reduction of the IOP postoperatively (group I: 3.5 ± 3.7 mm Hg (<i>p</i> = 0.005) and group II: 4.3 ± 4.1 mm Hg (<i>p</i> = 0.003)). The mean IOP for group III was 12.9 ± 3.7 mm Hg at visit 1 and did not change significantly (<i>p</i> = 0.353) at visit 2. In all three groups, there was no statistically significant change in ECD at the last visit.</p><p><strong>Conclusion: </strong>According to our results, both SLT and mCPC seem to be effective in lowering the IOP, without showing any statistically significant effect on ECD in patients with POAG.However, larger and longer-term studies are necessary to understand the effects of the SLT and mCPC procedures on ECD.</p><p><strong>How to cite this article: </strong>Garip Kuebler A, Priglinger S, Reznicek L. Micropulse Cyclophotocoagulation vs Selective Laser Trabeculoplasty: Effects on Corneal Endothelial Cells and Intraocular Pressure. J Curr Glaucoma Pract 2023;17(1):40-43.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"17 1","pages":"40-43"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6a/f0/jocgp-17-40.PMC10203327.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9518286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Current Glaucoma Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1